AK154
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AK154, covering 2025-04-06 to 2025-04-06. Get the full timeline:
Most recent: Clinical Trial Update: A Study of mRNA Vaccines AK154 Monotherapy or in Combination With AK104/AK112,and Sequential mFOLFIRINOX in Surgically Resected PDAC [Phase 1]